Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

With Cytori Therapeutics, The Waiting Is The Hardest Part
Seeking Alpha
Tuesday, August 14, 2012 - 11:09am
tags:
Cytori
Merck KGaA profit helped by Rebif sales, forex
Reuters
Tuesday, August 14, 2012 - 11:07am
tags:
earnings, Merck KGaA
7 Big-Pharma Stocks With Untapped Potential
TheStreet.com
Tuesday, August 14, 2012 - 11:07am
tags:
GSK, JNJ, Bristol-Myers Squibb, Sanofi, AstraZeneca, Abbott Laboratories, Bayer
Synergy Closing Key Trial; Decision On IRWD's Linaclotide Likely To Have Impact
Yahoo/Reuters
Tuesday, August 14, 2012 - 11:05am
tags:
Synergy Pharmaceuticals, linaclotide, constipation
Carl Icahn comments on warning letter sent by FDA to Forest Labs
Yahoo/Fly on the Wall
Tuesday, August 14, 2012 - 11:04am
tags:
FDA, warnings, Forest Labs, Carl Icahn
Array BioPharma loss narrows
Reuters
Tuesday, August 14, 2012 - 11:03am
tags:
Array Biopharma, earnings
FDA clears new flu vaccine for production by 6 manufacturers
Washington Post, DC
Tuesday, August 14, 2012 - 11:02am
tags:
FDA, Flu, vaccines, flu vaccines, GSK, Sanofi, Novartis
Docs Want Drugmakers To Do What?
Pharmalot
Tuesday, August 14, 2012 - 11:01am
tags:
physicians
Roche Worker Sues For Whistleblowing & Firing
Pharmalot
Tuesday, August 14, 2012 - 11:00am
tags:
Roche, Genentech, whistleblower lawsuits
GlaxoSmithKline: Don't Pass On This Long-Term Gem
Seeking Alpha
Tuesday, August 14, 2012 - 10:59am
tags:
GSK, Abbott Laboratories, Pfizer, Merck, JNJ, Human Genome Sciences
Pfizer sees 2012 adjusted R&D expenses $6.75B-$7.25B
Yahoo/Fly on the Wall
Tuesday, August 14, 2012 - 10:58am
tags:
Pfizer, R&D
Simcere Misses 2Q Estimates
Yahoo/AP
Tuesday, August 14, 2012 - 10:57am
tags:
earnings, Simcere
Novo Nordisk Still A Top-Notch Healthcare Growth Story
Seeking Alpha
Tuesday, August 14, 2012 - 10:56am
tags:
Novo Nordisk, AstraZeneca, Bristol-Myers Squibb, Sanofi, Eli Lilly
3 Things to Watch With Avanir Pharmaceuticals
Motley Fool
Tuesday, August 14, 2012 - 10:55am
tags:
Avanir
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Yahoo/AP
Tuesday, August 14, 2012 - 10:54am
tags:
Pfizer, AstraZeneca, Nexium, OTC
3 Innovative Biotech Stocks To Consider Today
Seeking Alpha
Monday, August 13, 2012 - 1:36pm
tags:
Celgene, OncoSec, Onyx, Bayer, Arqule
Bionor Pharma Rises As HIV Drug Study Gets Approval: Oslo Mover
Bloomberg
Monday, August 13, 2012 - 1:34pm
tags:
Bionor Pharma, HIV
Biotechs reinvent from the ground up to build value
Fierce Biotech
Monday, August 13, 2012 - 1:33pm
tags:
biotech
Buy Arena Before European Approval Comes Through
Seeking Alpha
Monday, August 13, 2012 - 1:27pm
tags:
Arena Pharmaceuticals, Europe, Belviq, Orexigen, Vivus
Pacira Pharmaceuticals Beats on the Top Line
Motley Fool
Monday, August 13, 2012 - 1:26pm
tags:
Pacira, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.